Bruno Coudert

13.7k total citations · 1 hit paper
194 papers, 6.9k citations indexed

About

Bruno Coudert is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Bruno Coudert has authored 194 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Oncology, 66 papers in Pulmonary and Respiratory Medicine and 58 papers in Cancer Research. Recurrent topics in Bruno Coudert's work include Cancer Treatment and Pharmacology (47 papers), Breast Cancer Treatment Studies (44 papers) and HER2/EGFR in Cancer Research (36 papers). Bruno Coudert is often cited by papers focused on Cancer Treatment and Pharmacology (47 papers), Breast Cancer Treatment Studies (44 papers) and HER2/EGFR in Cancer Research (36 papers). Bruno Coudert collaborates with scholars based in France, United States and Belgium. Bruno Coudert's co-authors include P. Fumoleau, Laurent Arnould, C. Focan, Sylvie Giacchetti, Françis Lévi, François Ghiringhelli, P. Chollet, D Larregain-Fournier, R. Adam and B Perpoint and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Bruno Coudert

187 papers receiving 6.7k citations

Hit Papers

Phase III Multicenter Randomized Trial of Oxaliplatin Add... 2000 2026 2008 2017 2000 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Coudert France 44 3.9k 1.2k 1.2k 1.1k 1.1k 194 6.9k
Alexander Marx Germany 55 2.5k 0.7× 1.3k 1.0× 853 0.7× 1.5k 1.3× 2.0k 1.9× 350 12.8k
Nathan Bahary United States 43 3.3k 0.8× 1.1k 0.9× 1.5k 1.2× 170 0.1× 1.8k 1.7× 186 6.3k
Manabu Fukumoto Japan 52 2.5k 0.6× 1.3k 1.0× 1.6k 1.4× 703 0.6× 4.3k 4.0× 319 9.5k
Barbara Jarząb Poland 49 2.6k 0.7× 1.3k 1.1× 2.0k 1.7× 829 0.7× 3.4k 3.1× 270 11.3k
Kensei Yamaguchi Japan 49 5.7k 1.5× 4.6k 3.7× 970 0.8× 705 0.6× 1.8k 1.6× 453 9.9k
Christian Brambilla France 57 2.8k 0.7× 2.6k 2.1× 1.4k 1.2× 247 0.2× 3.7k 3.4× 169 8.3k
Ludovic Lacroix France 47 2.7k 0.7× 2.3k 1.9× 2.0k 1.7× 451 0.4× 2.7k 2.5× 220 7.5k
Rolf K. Reed Norway 44 1.3k 0.3× 910 0.7× 681 0.6× 486 0.4× 2.0k 1.8× 235 7.7k
Pierre‐Jean Lamy France 31 1.4k 0.3× 839 0.7× 1.4k 1.2× 306 0.3× 1.1k 1.0× 123 3.3k
François Paris France 36 1.2k 0.3× 1.2k 0.9× 989 0.8× 1.5k 1.3× 3.1k 2.9× 90 6.3k

Countries citing papers authored by Bruno Coudert

Since Specialization
Citations

This map shows the geographic impact of Bruno Coudert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Coudert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Coudert more than expected).

Fields of papers citing papers by Bruno Coudert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Coudert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Coudert. The network helps show where Bruno Coudert may publish in the future.

Co-authorship network of co-authors of Bruno Coudert

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Coudert. A scholar is included among the top collaborators of Bruno Coudert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Coudert. Bruno Coudert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arnould, Laurent, Françoise Beltjens, Didier Mayeur, et al.. (2023). Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy. Breast Cancer. 30(6). 997–1007. 8 indexed citations
2.
Petitcollin, Antoine, Nicolas Azzopardi, Jean‐Yves Pierga, et al.. (2021). Population pharmacokinetics and exposure–response relationship of trastuzumab and bevacizumab in early-stage breast cancer. European Journal of Clinical Pharmacology. 77(12). 1861–1873. 5 indexed citations
3.
Cappelaere, B., Denis Feurer, Théo Vischel, et al.. (2020). Modeling Land Surface Fluxes from Uncertain Rainfall: A Case Study in the Sahel with Field-Driven Stochastic Rainfields. Atmosphere. 11(5). 465–465. 2 indexed citations
4.
Coudert, Bruno, J. Chirouze, Salah Er‐Raki, et al.. (2019). Ability of a soil–vegetation–atmosphere transfer model and a two-source energy balance model to predict evapotranspiration for several crops and climate conditions. Hydrology and earth system sciences. 23(12). 5033–5058. 13 indexed citations
5.
Richard, Corentin, Jean-David Fumet, Sandy Chevrier, et al.. (2018). Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer Patients. Clinical Cancer Research. 25(3). 957–966. 38 indexed citations
6.
Coudert, Bruno, J. Chirouze, Salah Er‐Raki, et al.. (2018). Evapotranspiration monitoring based on thermal infrared data over agricultural landscapes: comparison of a simple energy budget model and a SVAT model. SPIRE - Sciences Po Institutional REpository. 3 indexed citations
7.
Paris, Christophe, Pascal Dô, Bénédicte Mastroïanni, et al.. (2017). Association between lung cancer somatic mutations and occupational exposure in never-smokers. European Respiratory Journal. 50(4). 1700716–1700716. 12 indexed citations
8.
9.
Humbert, Olivier, Alexandre Cochet, Bruno Coudert, et al.. (2015). Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer. The Oncologist. 20(2). 94–104. 45 indexed citations
10.
Beltjens, Françoise, Aurélie Bertaut, Catherine Loustalot, et al.. (2015). HER2-positivity rates in breast cancer: no variation over time when clinicopathological features and testing are stable. European Journal of Cancer Care. 26(2). e12404–e12404. 6 indexed citations
12.
13.
Boulet, Gilles, Albert Olioso, Bruno Coudert, et al.. (2012). Reconstruction of temporal variations of evapotranspiration using instantaneous estimates at the time of satellite overpass. Hydrology and earth system sciences. 16(8). 2995–3010. 77 indexed citations
14.
Borget, Isabelle, Jacques Cadranel, Jean‐Pierre Pignon, et al.. (2011). Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3. European Respiratory Journal. 39(1). 172–179. 27 indexed citations
15.
Guiu, Séverine, Bruno Coudert, Laure Favier, Laurent Arnould, & P. Fumoleau. (2010). Thérapeutiques dans le cancer du sein métastatique HER2-positif : présent et futur. Bulletin du Cancer. 97(3). 365–383. 2 indexed citations
16.
Végran, Frédérique, Romain Boidot, Bruno Coudert, et al.. (2009). Gene expression profile and response to trastuzumab–docetaxel-based treatment in breast carcinoma. British Journal of Cancer. 101(8). 1357–1364. 25 indexed citations
17.
Fumoleau, P., et al.. (2007). [Targeting ErbB receptors in breast cancer].. PubMed. 94(7 Suppl). F147–70. 2 indexed citations
18.
Favier, Laure, Nicolás Isambert, Sylvie Zanetta, et al.. (2007). Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancer. The Breast. 17(1). 36–41. 6 indexed citations
19.
Fagnani, Francis, et al.. (2007). [Cost/effectiveness analysis of adjuvant therapy with trastuzumab in patients with HER2 positive early breast cancer].. PubMed. 94(7). 711–20. 12 indexed citations
20.
Arnould, Laurent, Frédérique Penault‐Llorca, L. Benoît, et al.. (2006). Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?. British Journal of Cancer. 94(2). 259–267. 424 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026